Literature DB >> 18052040

Carboxyl-terminal disulfide bond of acid sphingomyelinase is critical for its secretion and enzymatic function.

Ching Yin Lee1, Taku Tamura, Nadia Rabah, Dong-Young Donna Lee, Isabelle Ruel, Anouar Hafiane, Iulia Iatan, Dana Nyholt, Frédéric Laporte, Claude Lazure, Ikuo Wada, Larbi Krimbou, Jacques Genest.   

Abstract

The human acid sphingomyelinase (ASM, EC 3.1.4.12), a lysosomal and secretory protein coded by the sphingomyelin phosphodiesterase 1 (SMPD-1) gene, catalyzes the degradation of sphingomyelin (SM) to ceramide and phosphorylcholine. We examined the structural-functional properties of its carboxyl-terminus (amino acids 462-629), which harbors approximately 1/3 of all mutations discovered in the SMPD-1 gene. We created four naturally occurring mutants (DeltaR608, R496L, G577A, and Y537H) and five serial carboxyl-terminal deletion mutants (N620, N590, N570, N510, and N490). Transient transfection of the His/V5-tagged wild-type and mutant recombinant ASM in Chinese hamster ovary cells showed that all the mutants were normally expressed. Nonetheless, none of them, except the smallest deletion mutant N620 that preserved all post-translational modifications, were found capable of secretion to the medium. Furthermore, only the N620 conserved functional integrity (100% activity of the wild type); all other mutants completely lost the ability to catalyze SM hydrolysis. Importantly, cell surface biotinylation revealed that mutant DeltaR608 transfected CHO cells and fibroblasts from a compound heterozygous Niemann-Pick disease type B (NPD-B) patient (DeltaR608 and R441X) have defective translocation to the plasma membrane. Furthermore, we demonstrated that the DeltaR608 and N590 were trapped in the endoplasmic reticulum (ER) quality control checkpoint in contrast to the wild-type lysosomal localization. Interestingly, while the steady-state levels of ubiquitination were minimal for the wild-type ASM, a significant amount of Lys63-linked polyubiquitinated DeltaR608 and N590 could be purified by S5a-affinity chromatography, indicating an important misfolding in the carboxyl-terminal mutants. Altogether, we provide evidence that the carboxyl-terminus of the ASM is crucial for its protein structure, which in turns dictates the enzymatic function and secretion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18052040     DOI: 10.1021/bi700817g

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  A novel mechanism of lysosomal acid sphingomyelinase maturation: requirement for carboxyl-terminal proteolytic processing.

Authors:  Russell W Jenkins; Jolanta Idkowiak-Baldys; Fabio Simbari; Daniel Canals; Patrick Roddy; Clarke D Riner; Christopher J Clarke; Yusuf A Hannun
Journal:  J Biol Chem       Date:  2010-11-22       Impact factor: 5.157

2.  Solving the secretory acid sphingomyelinase puzzle: Insights from lysosome-mediated parasite invasion and plasma membrane repair.

Authors:  Norma W Andrews
Journal:  Cell Microbiol       Date:  2019-06-10       Impact factor: 3.715

3.  Regulated secretion of acid sphingomyelinase: implications for selectivity of ceramide formation.

Authors:  Russell W Jenkins; Daniel Canals; Jolanta Idkowiak-Baldys; Fabio Simbari; Patrick Roddy; David M Perry; Kazuyuki Kitatani; Chiara Luberto; Yusuf A Hannun
Journal:  J Biol Chem       Date:  2010-08-31       Impact factor: 5.157

Review 4.  Genetic convergence of Parkinson's disease and lysosomal storage disorders.

Authors:  Hao Deng; Xiaofei Xiu; Joseph Jankovic
Journal:  Mol Neurobiol       Date:  2014-08-07       Impact factor: 5.590

Review 5.  Roles and regulation of secretory and lysosomal acid sphingomyelinase.

Authors:  Russell W Jenkins; Daniel Canals; Yusuf A Hannun
Journal:  Cell Signal       Date:  2009-06       Impact factor: 4.315

6.  Sphingomyelin phosphodiesterase acid-like 3A (SMPDL3A) is a novel nucleotide phosphodiesterase regulated by cholesterol in human macrophages.

Authors:  Mathew Traini; Carmel M Quinn; Cecilia Sandoval; Erik Johansson; Kate Schroder; Maaike Kockx; Peter J Meikle; Wendy Jessup; Leonard Kritharides
Journal:  J Biol Chem       Date:  2014-10-06       Impact factor: 5.157

7.  Avicin G is a potent sphingomyelinase inhibitor and blocks oncogenic K- and H-Ras signaling.

Authors:  Christian M Garrido; Karen M Henkels; Kristen M Rehl; Hong Liang; Yong Zhou; Jordan U Gutterman; Kwang-Jin Cho
Journal:  Sci Rep       Date:  2020-06-04       Impact factor: 4.379

Review 8.  Keep Your Friends Close, but Your Enemies Closer: Role of Acid Sphingomyelinase During Infection and Host Response.

Authors:  Ha-Yeun Chung; Ralf A Claus
Journal:  Front Med (Lausanne)       Date:  2021-01-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.